Metabolic Health • Preventive Endocrinology

Insulin Resistance &
Metabolic Health

Metabolic dysfunction often develops years before diabetes or cardiovascular disease develops. Changes in insulin sensitivity, visceral fat, blood pressure, triglycerides, inflammation, sleep, and muscle mass can progress gradually, long before routine labs become clearly abnormal.

At Well Endocrinology, metabolic health is approached through evidence-based endocrinology, obesity medicine, and prevention-focused care designed to identify metabolic dysfunction early and reduce long-term disease risk before progression occurs.

Metabolic health and lifestyle medicine

Metabolic dysfunction is often missed early

Many patients are told their labs are “normal” despite clear signs of metabolic dysfunction.

Insulin resistance and prediabetes frequently develop years before type 2 diabetes is diagnosed. During that time, patients may experience progressive metabolic changes long before fasting glucose or A1C become clearly abnormal.

Early identification matters. Evaluation includes assessment of insulin resistance, metabolic syndrome, and overall cardiometabolic health before more advanced disease develops.

01
Weight loss resistance

Insulin resistance may contribute to persistent difficulty losing weight despite significant effort with diet and exercise.

02
Visceral fat accumulation

Abdominal weight gain and increasing visceral adiposity are strongly associated with worsening cardiometabolic risk.

03
Glucose variability

Energy crashes, post-meal fatigue, increased hunger, and fluctuating glucose patterns may reflect underlying insulin resistance.

04
Progressive metabolic risk

Metabolic syndrome increases long-term risk for type 2 diabetes, fatty liver disease, cardiovascular disease, stroke, and cognitive decline.

What a metabolic health evaluation includes

Metabolic assessment goes beyond routine screening labs alone. Evaluation may include body composition patterns, insulin resistance markers, hormonal influences on metabolism, lifestyle contributors, and long-term cardiometabolic risk assessment.

01 • Insulin Resistance

Insulin resistance

Reduced sensitivity to insulin may contribute to elevated glucose, increased hunger, fatigue, abdominal weight gain, and progression toward type 2 diabetes.

02 • Prediabetes

Prediabetes

Prediabetes is often reversible when identified early. Evaluation focuses on glucose regulation, metabolic risk progression, and prevention-focused intervention.

03 • Metabolic Syndrome

Metabolic syndrome

We evaluate the cluster of findings associated with metabolic syndrome, including abdominal adiposity, elevated blood pressure, abnormal lipids, and impaired glucose regulation.

04 • Body Composition

Visceral adiposity

Visceral fat accumulation around abdominal organs carries substantially greater metabolic risk than weight alone and may worsen insulin resistance and inflammation.

05 • PCOS

PCOS-related metabolic dysfunction

PCOS is strongly associated with insulin resistance and increased long-term metabolic risk, even in patients without obesity. Learn more about PCOS care.

06 • Menopause

Menopause-related metabolic changes

Hormonal shifts during perimenopause and menopause can worsen insulin resistance, visceral adiposity, muscle loss, and cardiovascular risk patterns. Explore menopause care.

07 • Fatty Liver

Fatty liver risk

Metabolic dysfunction commonly contributes to fatty liver disease, often before symptoms develop or liver enzymes become significantly abnormal.

08 • Prevention

Cardiometabolic risk reduction

The goal is not simply improving laboratory values. Treatment is focused on reducing long-term disease risk while improving day-to-day metabolic health and function.

Lifestyle Intervention

Lifestyle intervention, grounded in endocrinology

Lifestyle intervention is foundational to metabolic health, but effective care requires more than generic advice. Insulin resistance, hormonal shifts, sleep disruption, appetite regulation, muscle mass, stress physiology, and menopause-related metabolic changes all affect how the body responds to nutrition and exercise.

Recommendations are individualized, evidence-based, and designed to improve insulin sensitivity and long-term metabolic function in ways that are sustainable outside of an idealized routine.

Treatment plans may also incorporate evidence-based obesity medicine when clinically appropriate.

Protein and fiber optimization
Resistance training strategies
Nutrition approaches designed to improve insulin sensitivity
Sleep and circadian rhythm support
Body composition preservation
Sustainable activity planning
South Asian Metabolic Risk

Metabolic risk can look different in South Asian patients

South Asian patients often develop insulin resistance, prediabetes, fatty liver disease, and type 2 diabetes at younger ages and lower BMI thresholds compared with other populations. Traditional screening methods may underestimate risk, particularly when weight appears “normal.”

This pattern is common, underrecognized, and clinically important. Metabolic risk assessment should account for ethnic and genetic risk factors rather than relying on weight alone.

Increased visceral adiposity
Early insulin resistance
Strong family history of diabetes
Gestational diabetes history
Sarcopenic obesity patterns
Elevated cardiovascular risk despite lower BMI
A young woman with dark hair tied back, wearing a light gray hoodie, stands by a body of water, looking down thoughtfully with her hands near her face.
A young couple holding and looking lovingly at their newborn baby wrapped in a star-printed blanket indoors near a window.
A young man with dark hair and a beard, wearing a black hoodie, standing outdoors with a blurred cityscape in the background.
Our Approach

Prevention-focused metabolic care

Care is individualized, physician-led, and designed around long-term metabolic health. Treatment plans are tailored to physiology, lifestyle, risk profile, and sustainable outcomes rather than short-term restriction alone.

01

Detailed evaluation

Assessment may include insulin resistance, metabolic syndrome, body composition, hormonal influences, and long-term cardiometabolic risk.

02

Personalized treatment

Recommendations are individualized and may include nutrition strategies, resistance training, obesity medicine, and metabolic risk reduction.

03

Physician-led follow-up

Patients work directly with Dr. Sobia Sadiq throughout care, with ongoing follow-up designed around long-term progress and prevention.

04

Evidence-based care

Treatment decisions are grounded in endocrinology, obesity medicine, and current evidence rather than wellness trends or restrictive protocols.

Related Reading

Further reading on metabolic health

FAQ

Common questions about metabolic health

Common signs may include abdominal weight gain, difficulty losing weight, fatigue after meals, elevated triglycerides, blood sugar variability, skin tags, acanthosis nigricans, and prediabetes.

Yes. Insulin resistance often develops years before fasting glucose or A1C become abnormal. A normal A1C does not necessarily rule out metabolic dysfunction.

Metabolic syndrome refers to a cluster of metabolic risk factors that increase the likelihood of type 2 diabetes and cardiovascular disease, including abdominal adiposity, elevated blood pressure, abnormal cholesterol patterns, and impaired glucose regulation.

In many cases, yes. Early intervention, lifestyle modification, improved sleep, exercise, weight reduction, and appropriate medical treatment can substantially improve metabolic health and reduce long-term disease risk.

South Asians frequently develop insulin resistance and visceral adiposity at lower BMI thresholds, increasing risk for diabetes and cardiovascular disease even when body weight appears relatively normal.

Well Endocrinology

Metabolic health deserves earlier attention

Insulin resistance, prediabetes, and metabolic dysfunction often develop gradually over time. Early intervention can meaningfully reduce long-term health risk and improve day-to-day metabolic health.